Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial. (2021)

First Author: Mäki-Petäjä KM
Attributed to:  Cambridge Mathematics of Information in Healthcare (CMIH) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/hypertensionaha.120.16454

PubMed Identifier: 33775123

Publication URI: http://europepmc.org/abstract/MED/33775123

Type: Journal Article/Review

Volume: 77

Parent Publication: Hypertension (Dallas, Tex. : 1979)

Issue: 5

ISSN: 0194-911X